KAREN SMITH: Open Payments
NPI 1255831657 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 45 payments from 11 companies in 2025. Trend: 2023 $21 · 2024 $240 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $419 |
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| Exact Sciences Corporation | 4 | $73 |
| Lilly USA, LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Amgen Inc. | 3 | $46 |
| Baxter Healthcare | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: QULIPTA, AIRSUPRA, VRAYLAR, UBRELVY, EPKINLY, MOUNJARO, CAPLYTA, OTEZLA.
Industry payments across OK — which companies pay providers there.
